In this Demystifying Medicine video from McMaster University, learn more about idiopathic pulmonary fibrosis (IPF), a scleroderma-related condition that currently has no known cause. Back in February, researchers presented a study investigating the therapeutic effect of the monoclonal antibody CM-101 in animal models of systemic sclerosis (SSc) and…
Gallery
Social Clips
Scleroderma and the GI Tract
In this video by the Scleroderma Foundation, Greater Chicago Chapter, watch Michael Brown, MD, Professor of Medicine, Rush University Medical Center, talk about scleroderma and the gastrointestinal tract (GI). Read the latest scleroderma and gastrointestinal (GI) problems news here: https://bit.ly/1ZGMEEZ…
Recent Posts
- Carbon dioxide hand baths may help in SSc-related Raynaud’s, study finds
- More SSc-ILD patients receive early treatment, new study finds
- CD13 levels elevated in scleroderma, but biomarker value unclear
- New lab findings support development of stem cell treatments for SSc-ILD
- Type of immune cell may be key driver of scleroderma scarring: Study
- Abnormal fatty acid metabolism may play role in scleroderma: Analysis
- Cosmetic laser therapy could be repurposed for localized scleroderma
- Antibody levels may help reflect quality of life in people with scleroderma
- Certain antibodies tied to poorer outcomes in systemic sclerosis
- Dexamethasone reduces inflammation, scarring in SSc mouse model: Study